ArticleGastro hep advances2022

In Vivo Screen Identifies Liver X Receptor Alpha Agonism Potentiates Sorafenib Killing of Hepatocellular Carcinoma.

A M Vázquez Salgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.